Boosting BCG with Recombinant Modified Vaccinia Ankara Expressing Antigen 85A: Different Boosting Intervals and Implications for Efficacy Trials

OBJECTIVES: To investigate the safety and immunogenicity of boosting BCG with modified vaccinia Ankara expressing antigen 85A (MVA85A), shortly after BCG vaccination, and to compare this first with the immunogenicity of BCG vaccination alone and second with a previous clinical trial where MVA85A was...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathan, Ansar A., Sander, Clare R., Fletcher, Helen A., Poulton, Ian, Alder, Nicola C., Beveridge, Natalie E. R., Whelan, Kathryn T., Hill, Adrian V. S., McShane, Helen
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034536/
https://www.ncbi.nlm.nih.gov/pubmed/17957238
http://dx.doi.org/10.1371/journal.pone.0001052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034536/
https://www.ncbi.nlm.nih.gov/pubmed/17957238
http://dx.doi.org/10.1371/journal.pone.0001052

Ejemplares similares